Sector
ChemicalsOpen
₹908.2Prev. Close
₹903.45Turnover(Lac.)
₹64.51Day's High
₹908.2Day's Low
₹893.952 Week's High
₹1,650.8552 Week's Low
₹788.5Book Value
₹310.48Face Value
₹10Mkt Cap (₹ Cr.)
2,100.61P/E
158.92EPS
5.68Divi. Yield
0.22Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 23.39 | 22.17 | 22.17 | 20.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 702.49 | 482.62 | 446.71 | 141.85 |
Net Worth | 725.88 | 504.79 | 468.88 | 161.94 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 |
---|---|
Revenue | 291.18 |
yoy growth (%) | |
Raw materials | -145.71 |
As % of sales | 50.04 |
Employee costs | -24.13 |
Y/e 31 Mar( In .Cr) | Mar-2021 |
---|---|
Profit before tax | 59.34 |
Depreciation | -6.73 |
Tax paid | -7.98 |
Working capital | |
Other operating items |
Y/e 31 Mar | Mar-2021 |
---|---|
Growth matrix (%) | |
Revenue growth | |
Op profit growth | |
EBIT growth | |
Net profit growth |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 393.5 | 423.61 | 433.65 | 300.36 | 263.24 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 393.5 | 423.61 | 433.65 | 300.36 | 263.24 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 7.51 | 5.74 | 9.02 | 5.2 | 1.38 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Pidilite Industries Ltd PIDILITIND | 3,191.2 | 82.67 | 1,62,474.04 | 542 | 0.5 | 2,976.92 | 169.8 |
SRF Ltd SRF | 2,336.45 | 58.96 | 69,275.96 | 225.11 | 0.31 | 2,615.87 | 367.56 |
Linde India Ltd LINDEINDIA | 6,789.7 | 132.45 | 57,934.54 | 104.39 | 0.18 | 634.42 | 416.08 |
Gujarat Fluorochemicals Ltd FLUOROCHEM | 4,484.4 | 123.9 | 49,160.07 | 144 | 0.07 | 1,199 | 559.21 |
Deepak Nitrite Ltd DEEPAKNTR | 2,736.8 | 110.68 | 37,256.44 | 142.27 | 0.27 | 604.7 | 224.1 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Chintan Nitinkumar Shah
Whole-time Director
Ajaykumar Mansukhlal Patel
Whole-time Director
Shekhar Rasiklal Somani
Independent Non Exe. Director
Subhash Patel
Independent Non Exe. Director
Avani Rajesh Umatt
Independent Non Exe. Director
Manher Chinmanlal Desai
Company Sec. & Compli. Officer
Ishwar Nayi
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Tatva Chintan Pharma Chem Ltd
Summary
Tatva Chintan Pharma Chem Limited was formerly incorporated as Tatva Chintan Pharma Chem Private Limited on 12 June 1996. The status of the Company converted from Private Limited into a Public Limited Company effective from 27 January 2021 and the name of Company also changed from Tatva Chintan Pharma Chem Private Limited to Tatva Chintan Pharma Chem Limited. The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani. The Company is a globally recognized specialty chemical player with several market leading products in its portfolio. The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), , Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC). These products cater to diverse industries such as pharmaceuticals, agrochemicals, automotive, electronics, resins and polymers, flavours and fragrances, personal care and disinfectants, oil field and energy storage.The Company operate through two world class manufacturing facilities located at Dahej and Ankleshwar in Gujarat both of which are strategically located very close to the Hazira Port. These units provide the Company cost and logistics advantage and enabling seamless export and import operations. The Companys manufacturing facilities obtained ISO 9001:2015 and 14001:2015 certification
Read More
The Tatva Chintan Pharma Chem Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹898 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tatva Chintan Pharma Chem Ltd is ₹2100.61 Cr. as of 12 Dec ‘24
The PE and PB ratios of Tatva Chintan Pharma Chem Ltd is 158.92 and 2.93 as of 12 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Tatva Chintan Pharma Chem Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Tatva Chintan Pharma Chem Ltd is ₹788.5 and ₹1650.85 as of 12 Dec ‘24
Tatva Chintan Pharma Chem Ltd's CAGR for 5 Years at -17.13%, 3 Years at -28.35%, 1 Year at -43.75%, 6 Month at -10.55%, 3 Month at -6.19% and 1 Month at 3.35%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice